Sustained improvement in dark-adapted sensitivity but not BCVA after voretigene neparvovec treatment in a mainland Chinese child with biallelic RPE65-associated LCA2: a case report.

Luxturna (voretigene neparvovec-rzyl) - Novartis, Roche

http://www.ncbi.nlm.nih.gov/pubmed/42755963

Chunhui Zheng; Di Wang; Jia Rong; Jijing Pang; Jun Li; Ling Xu; Shu Liu; Wensheng Li; Yanbo Liu; Yue Ren; Zhuoshi Wang

Sep 19, 2026